TIS tissue therapies limited

Ann: Regulatory Update , page-6

  1. 287 Posts.
    lightbulb Created with Sketch. 198
    Oh boy, where to begin... how about the plausible deniability claim ("...EMA process excludes sponsor companies like TIS from direct contact..."). Thing is, they've been able to access and assess the BSI submission in the last 5 days, no doubt in panic, only to discover "oh dear, that's not very good, is it?". If the bureacrats exclude you, fine you can't control that, but at least manage what those putting your case forward are saying - before they submit it, not after!

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.